Concepedia

Publication | Closed Access

Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial

DOI

94

Citations

36

References

2017

Year

Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Richard L. White, James Granfortuna, Judith O. Hopkins, Dwight S. Oldham, Angel Rodriguez,
Journal of Surgical Oncology

Abstract

Using the RS to guide NST is feasible. These results suggest that for patients with RS < 25 NHT is a potentially effective strategy.

References

YearCitations

Page 1